Industrivarden AB operates within the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Industrivarden AB with three other
financial institutions in Europe:
BB Biotech AG
sales of 270.33 million Swiss Francs [US$281.89 million]
of which 100%
was Investing & Related Activity),
Deutsche Balaton AG
(186.45 million Euro [US$219.09 million]
of which 38%
was CornerstoneCapital), and
based in France
(235.02 million Euro [US$276.17 million]
of which 81%
was Financial Investments).
During the year ended December of 2017, sales at
Industrivarden AB were SEK 2.79 billion (US$317.05 million).
decrease of 9.5%
versus 2016, when the company's sales were SEK 3.08 billion.